Erythromycin derivative
US5175150A · kind A · utility
20Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1990 |
| Grant date | Dec 29, 1992 |
| Priority date | — |
| Expiry date | Dec 17, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel erythromycin derivatives, or salts thereof, represented by the following general formula: ##STR1## and processes for preparing the same. The erythromycin derivatives described above have an excellent effect of stimulating the gastrointestinal contractile motion and have low toxicity, and the preparations containing these compounds can be advantageously used as digestive tract contractile motion stimulants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.